|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:24:13 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 1.900 ILa | +5.56% |
|
+5.56% | -20.83% |
| 06-30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 06-29 | XTL Biopharmaceuticals Ltd. acquired Psyga Bio Ltd. | CI |
Chart: Technical Analysis
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| XTLB | Delayed | |
CBOE
| XTLB | Real-time | |
|
Deutsche Boerse AG
| HHB0 | Delayed | |
|
Börse Stuttgart
| HHB0 | Delayed | |
|
Boerse Muenchen
| HHB0 | Real-time | |
TEL AVIV STOCK EXCHANGE
| XTLB | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2 | 2.2 | 2.2 |
| Spread/Res. | -5.00% | -13.64% | -13.64% |
| Spread/Supp. | +5.56% | +18.75% | +11.76% |
| Support | 1.8 | 1.6 | 1.7 |
- Stock Market
- Stocks
- XTLB Stock
- Charts XTL Biopharmaceuticals Ltd.
Select your edition
All financial news and data tailored to specific country editions
